However, Pfizer and Germany’s BioNTech said they would provide their vaccine to COVAX at an undisclosed “not-for-profit price.” The companies still must execute a supply agreement covering distribution, but the doses are to be delivered throughout 2021, starting in February.
© Copyright 2021 The Washington Times, LLC
3600 New York Avenue NE, Washington, DC 20002